MEDINDIA

Search Medindia

Latest Press Releases

Health News Posted on Tuesday, December 9, 2025

Premium Press Releases »

Geneva College of Longevity Science and DrVibe.ai Launch the GCLS AI Academy for Longevity Sciences

New Website:  https://gcls.ai GENEVA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Geneva College of Longevity Science (GCLS) , in partnership with DrVibe.ai , today announced the launch of the GCLS AI Academy for Longevity Sciences —the ...

Read More

CLINUVEL Expands Singapore RD&I Centre to Pioneer Next-generation Peptide Therapies

EXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating development of liquid long-acting drug delivery platforms existing RD&I teams will advance ...

Read More

A New Era in Imaging – How is United Imaging Responding to the Needs of the 21st Century?

An aging population, an increase in lifestyle diseases, and the need for rapid and accurate diagnostics are driving technological transformation in medical facilities. Modern imaging systems can no longer be just “cameras” – they must become ...

Read More

Philips Reiterates Timing of 2026 Outlook

December 4, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously ...

Read More

Press Releases »

Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)

PR Newswire GOTHENBURG, Sweden, Dec. 8, 2025 GOTHENBURG, Sweden, Dec. 8, 2025 /PRNewswire/ -- Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare ...

Read More

Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US

PR Newswire LONDON, Dec. 8, 2025 Ready-to-use sepsis therapy marks new advancement in time-critical treatment LONDON, Dec. 8, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today ...

Read More

Hemab Therapeutics Announces Positive Complete Phase 2 Data for Sutacimig in Glanzmann Thrombasthenia at ASH 2025; Plans to Advance to Pivotal Phase 3 Study

PR Newswire CAMBRIDGE, Mass. and COPENHAGEN, Denmark, Dec. 8, 2025 Consistent and robust efficacy demonstrated across bleed types, locations, and dose cohorts The weekly dosing cohort achieved an estimated 87% reduction in annualized ...

Read More

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

PR Newswire FLORENCE, Italy and NEW YORK, Dec. 8, 2025 FLORENCE, Italy and NEW YORK, Dec. 8, 2025 /PRNewswire/ -- The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, ...

Read More

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

PR Newswire PROVIDENCE, R.I., Dec. 8, 2025 PROVIDENCE, R.I., Dec. 8, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study ...

Read More

Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight

PR Newswire HONG KONG, Dec. 8, 2025 -  ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no observed plateau for weight loss. -  ASC30 ...

Read More

GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'

PR Newswire YONGIN, South Korea, Dec. 8, 2025 - First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025 ...

Read More

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

PR Newswire BRUSSELS, Dec. 8, 2025 BRUSSELS, Dec. 8, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study investigating adjunctive fenfluramine in ...

Read More

HCMCT Manipal Hospitals Delhi, India performs lifesaving heart transplant on a 54-year-old woman

PR Newswire NEW DELHI, Dec. 8, 2025 NEW DELHI, Dec. 8, 2025 /PRNewswire/ -- In a significant medical achievement, doctors at HCMCT Manipal Hospitals in Delhi, India, successfully performed a life-saving heart transplant on a 54-year-old ...

Read More

IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH

PR Newswire SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 7, 2025 SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 7, 2025 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company ...

Read More

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

PR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, ...

Read More

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

PR Newswire TOKYO, Dec. 8, 2025 TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million (USD 460,0001) for the development of a prototype detection ...

Read More

CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting

PR Newswire SHANGHAI, Dec. 7, 2025 SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its ...

Read More

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

PR Newswire SINGAPORE, Dec. 7, 2025 SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health Sciences Authority (HSA) for its 1Bio™AI-Acute toolbox as a Class B software-as-a-medical ...

Read More

Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)

PR Newswire INDIANAPOLIS, Dec. 7, 2025 In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% for ...

Read More

TODAY SHOW EXPOSES AI MEDICAL SCAMS TARGETING LIPEDEMA PATIENTS

PR Newswire LOS ANGELES, Dec. 5, 2025 LOS ANGELES, Dec. 5, 2025 /PRNewswire/ -- AI-generated deepfake scams are rapidly spreading across social media, using fabricated videos, synthetic voices, and fake medical experts to promote unverified ...

Read More

Schweiger Dermatology Group Expands Access to Dermatology Care with Same-Week Appointments and Advanced Skin Cancer Treatment

PR Newswire NEW YORK, Dec. 5, 2025 NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Schweiger Dermatology Group, one of the nation's fastest-growing and most comprehensive dermatology practices, today announced a landmark year of accelerated growth, ...

Read More

AL-S Pharma Reports Positive Results from Phase 2 Study of AP-101 for the Treatment of ALS, Supporting Plans for a Confirmatory Phase 3 Study

PR Newswire ZURICH, Switzerland, Dec. 5, 2025 ZURICH, Switzerland, Dec. 5, 2025 /PRNewswire/ -- AL-S Pharma, a clinical-stage biotech company dedicated to the development of AP-101 for the treatment of amyotrophic lateral sclerosis (ALS) ...

Read More

United Nations Adopts International Mediterranean Diet Day

PR Newswire NEW YORK, Dec. 5, 2025 The Municipality of Pollica Takes Center Stage in New York: From Emblematic Community to Lead of the International Secretariat NEW YORK, Dec. 5, 2025 /PRNewswire-PRWeb/ -- The negotiations on the ...

Read More

American Nurses Association Reaffirms Support for Evidence-Based Immunizations Following CDC Panel Vote on Hepatitis B Vaccine

PR Newswire SILVER SPRING, Md., Dec. 5, 2025 ANA Urges Evidence-Based Decision-Making and Policies that Protect the Health of Infants, Families, and Communities SILVER SPRING, Md., Dec. 5, 2025 /PRNewswire/ -- The American Nurses ...

Read More

A New Era in Imaging – How is United Imaging Responding to the Needs of the 21st Century?

An aging population, an increase in lifestyle diseases, and the need for rapid and accurate diagnostics are driving technological transformation in medical facilities. Modern imaging systems can no longer be just “cameras” – they must become ...

Read More

TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet

PR Newswire NANJING, China and GAITHERSBURG, Md., Dec. 4, 2025 NANJING, China and GAITHERSBURG, Md., Dec. 4, 2025 /PRNewswire/ -- TransThera Sciences Inc. ("TransThera") announced the publication of clinical results from a US-based Phase 2 ...

Read More

Human Longevity Expands $1M Cancer Pledge to Redefine Early Detection and Prevention of Colon Cancer

PR Newswire SOUTH SAN FRANCISCO, Calif., Dec. 4, 2025 SOUTH SAN FRANCISCO, Calif., Dec. 4, 2025 /PRNewswire/ -- Human Longevity, Inc. (HLI), the global leader in precision health and longevity medicine, today announced the expansion of its ...

Read More

FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness

PR Newswire WASHINGTON, Dec. 4, 2025 WASHINGTON, Dec. 4, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on protocol ...

Read More

MySmile Launches New Year Oral Care Campaign: "New Year, New Smile" -- Encouraging Everyone to Upgrade Their Daily Routine for a Brighter, Healthier You

PR Newswire LOS ANGELES, Dec. 4, 2025 LOS ANGELES, Dec. 4, 2025 /PRNewswire/ -- As the world welcomes a fresh start, MySmile, a leader in at-home teeth whitening and advanced oral care, is kicking off the year with a powerful message: New ...

Read More

Discovery could give investigators a new tool in death investigations

PR Newswire MIAMI, Dec. 4, 2025 MIAMI, Dec. 4, 2025 /PRNewswire/ -- A discovery by FIU researchers could help forensic investigators close the gap on estimating time of death.   Often, death investigations rely on maggots — the ...

Read More

mlHealth 360 Receives FDA Clearance for Scaida BrainCT-ICH: Canada's First AI Solution for Intracranial Hemorrhage Triage

PR Newswire SURREY, BC, Dec. 4, 2025 SURREY, BC, Dec. 4, 2025 /PRNewswire/ - mlHealth 360 today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K250694) for Scaida BrainCT-ICH, an AI-powered triage ...

Read More

Air Pollution Linked to More Severe Heart Disease

PR Newswire CHICAGO, Dec. 4, 2025 CHICAGO, Dec. 4, 2025 /PRNewswire/ -- Long-term exposure to common air pollutants is associated with more advanced coronary artery disease—with notable differences between women and men—according to a ...

Read More

Generic Injectables Market Dominated by Hospital Pharmacies with 61.23% Share as Online Pharmacies Surge at 18.06% CAGR Through 2030, Reports Mordor Intelligence

PR Newswire HYDERABAD, India, Dec. 4, 2025 HYDERABAD, India, Dec. 4, 2025 /PRNewswire/ -- According to a recent report by Mordor Intelligence, the generic injectables market size is valued at USD 131.68 billion in 2025 and is projected to ...

Read More

Fitterfly (a division of PB Health) Secures Patent for PGR Technology to Drive Better Diabetes Outcomes

PR Newswire MUMBAI, India, Dec. 4, 2025 In an industry first, Fitterfly by PB Health has secured a Govt. of India patent for its Personalised Glycemic Response (PGR) technology. It shows how food and activity may affect blood sugar up to ...

Read More
More Press Releases
⬆️